Larvol Delta - Therapeutic-Use-of-Tadekinig-Alfa-in-NLRC4-Mutation-and-XIAP-Deficiency-as-Open-Label-Extension

tadekinig alfa (IL-18BP) - AB2 Bio

http://clinicaltrials.gov/ct2/show/NCT03512314

Apr 23, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next